Norepinephrine in 0.9% Sodium Chloride
Injection will help meet critical supply reliability
and patient safety needs
ROSEMONT, Ill., May 22, 2024
/PRNewswire/ -- It is a New Day for Norepinephrine! Long Grove
Pharmaceuticals now offers ready-to-use Norepinephrine in 0.9%
Sodium Chloride in the 16 mg/250mL (64 mcg/mL) strength and
anticipates the availability of the 4 mg/250 mL (16 mcg/mL) and 8
mg/250 mL (32 mcg/mL) strengths in early summer.
Long Grove Pharmaceuticals Launches Premix
Norepinephrine
This ready-to-use premix has a 24-month shelf life at room
temperature and is safe to use up to seven days after removal from
the foil overwrap. A new source for Norepinephrine is a much needed
addition to the fragile critical care supply chain. The convenience
and safety of this manufactured premix formulation will help
hospital pharmacies focus their limited resources on addressing
unique and critical patient needs.
"We're very happy to help play a role in relieving some of the
stresses that our hospital pharmacy colleagues face every day. Over
the last six months, we have met with many customers who have
shared their ongoing challenges and have been very supportive of
our efforts to bring a safe, convenient premix Norepinephrine to
market," said Peter Karas, Chief Commercial Officer of Long
Grove Pharmaceuticals.
Norepinephrine in 0.9% Sodium Chloride Injection is indicated to
raise blood pressure in adult patients with severe, acute
hypotension, and it is one of the most commonly used injectable
medications in the critical care setting.
For ordering information or to learn more about Long Grove
Pharmaceuticals, please visit www.longgrovepharma.com
About Long Grove Pharmaceuticals
Long Grove
Pharmaceuticals, LLC was established in 2019 by Water Street
Healthcare Partners. The company is part of Capstone Development
Services, LLC, which has been developing products in partnership
with the world's premier pharmaceutical and medical device
organizations since 2013. Combining decades of pharmaceutical and
hospital leadership experience with a portfolio of specialized,
complex drug formulations, Long Grove Pharmaceuticals is delivering
differentiated products that increase hospital pharmacy operational
efficiency and help improve the quality of patient care.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/long-grove-pharmaceuticals-launches-premix-norepinephrine-302153136.html
SOURCE Long Grove Pharmaceuticals